Concepedia

Intravitreal Bevacizumab (Avastin) for Myopic Choroidal Neovascularization

Wai‐Man Chan, Timothy Y. Y. Lai, David T.L. Liu, Dennis S.C. Lam

Ophthalmology · 2007 · 135 citations · 30 references

Concepts

PharmacyOphthalmologyPharmacotherapyOcular Drug DeliveryOcular PharmacologyOphthalmic Drug DeliveryIntraocular TumorsOcular Targeted DeliveryRetinal PharmacotherapyTopical Ocular Drug DeliveryVitreoretinal SurgeryVitreous Drug DeliveryChoroidal VasculatureDrug Delivery To The ChoroidMyopic Choroidal NeovascularizationMyopic CnvNeovascularization

References

30

A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry et al. · New England Journal of Medicine · 2003 · 2.7K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology · 2006 · 1.1K citations

Medicine, Ophthalmology, Pharmacotherapy +14

Proper Method for Calculating Average Visual Acuity

Jack T. Holladay · Journal of Refractive Surgery · 1997 · 1.1K citations

Medicine, Ophthalmology, Optometry +11

Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, Andrew A. Moshfeghi, Carmen A. Puliafito · Ophthalmic surgery, lasers & imaging retina · 2005 · 907 citations

Medicine, Ophthalmology, Pharmacotherapy +17

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study

S. Michels, Philip J. Rosenfeld, C PULIAFITO et al. · Ophthalmology · 2005 · 669 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13